Preventing Coronary Occlusion in an Elderly Severe Aortic Stenosis Patient with Critically Low Coronary Heights – A Case Report
Article Sidebar
Main Article Content
Abstract
Background: Transcatheter Aortic Valve Replacement (TAVR) is an established treatment for severe, symptomatic Aortic Stenosis (AS). However, the presence of low coronary heights confers a high risk for coronary obstruction during or after TAVR.
Case: In this case report, we present our experience with transfemoral-TAVR in an elderly, high-risk (STS score – 12.08%) female severe AS patient with low coronary heights (right: 7.4 mm, left: 8.7 mm). She had lower annulus area (287 mm2) and moderately low valve area (0.7 cm2) as well. Her mean and peak pressure gradients (PGs) were 38 mmHg and 61 mmHg, respectively. Upon the Heart Team’s evaluation, TAVR was recommended and a 20 mm Balloon Expandable (BE) Myval Transcatheter Heart Valve (THV) was selected. No peri-procedural or post-procedural complications were reported and the post-procedural hemodynamics, namely the mean and peak PGs improved to 16 mmHg and 30 mmHg after TAVR, respectively. The patient was discharged in a stable condition after four days of hospital stay.
Conclusion: We report the successful implantation of a small-sized BE Myval THV (20 mm) in a patient with low coronary heights. Life-threatening complications including paravalvular leak, coronary obstruction, or annular rupture were well averted; hence, we ascertain that the Myval THV is a suitable device for treating severe AS in difficult anatomies. However, the viability of the novel valve needs to be reaffirmed in larger studies
Article Details
Copyright (c) 2023 Kumar V, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, Zühlke L, Prendergast BD. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021 Dec;18(12):853-864. doi: 10.1038/s41569-021-00570-z. Epub 2021 Jun 25. PMID: 34172950. DOI: https://doi.org/10.1038/s41569-021-00570-z
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med Sci (Basel). 2022 Jun 15;10(2):32. doi: 10.3390/medsci10020032. PMID: 35736352; PMCID: PMC9228968. DOI: https://doi.org/10.3390/medsci10020032
Santangelo G, Bursi F, Faggiano A, Moscardelli S, Simeoli PS, Guazzi M, Lorusso R, Carugo S, Faggiano P. The Global Burden of Valvular Heart Disease: From Clinical Epidemiology to Management. J Clin Med. 2023 Mar 10;12(6):2178. doi: 10.3390/jcm12062178. PMID: 36983180; PMCID: PMC10054046. DOI: https://doi.org/10.3390/jcm12062178
Hanzel GS. Transcatheter aortic valve replacement. In: Aortic Stenosis: Case-Based Diagnosis and Therapy. Springer-Verlag London Ltd. 2015; 253–69. DOI: https://doi.org/10.1007/978-1-4471-5242-2_15
Tam DY, Azizi PM, Fremes SE, Chikwe J, Gaudino M, Wijeysundera HC. The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. Eur Heart J Qual Care Clin Outcomes. 2021 Oct 28;7(6):556-563. doi: 10.1093/ehjqcco/qcaa058. PMID: 32645146. DOI: https://doi.org/10.1093/ehjqcco/qcaa058
Boskovski MT, Nguyen TC, McCabe JM, Kaneko T. Outcomes of Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis: A Review of a Disruptive Technology in Aortic Valve Surgery. JAMA Surgery. American Medical Association. 2020; 155:69–77. DOI: https://doi.org/10.1001/jamasurg.2019.4449
Kim H, Lee SJ, Hong SJ, Shim CY, Ahn CM, Kim JS, Kim BK, Hong GR, Ko YG, Choi D, Jang Y, Hong MK. Clinical Outcomes of Transcatheter Aortic Valve Implantation for Native Aortic Valves in Patients with Low Coronary Heights. Yonsei Med J. 2021 Mar;62(3):209-214. doi: 10.3349/ymj.2021.62.3.209. PMID: 33635010; PMCID: PMC7934105. DOI: https://doi.org/10.3349/ymj.2021.62.3.209
Sengottuvelu G, Kumar V, Seth A. The Myval Transcatheter Heart Valve System for the Treatment of Severe Aortic Stenosis – Current Evidence and Future Directions. Heart Int. 2020;14(2):86. https://www.touchcardio.com/interventional-cardiology/journal-articles/the-myval-transcatheter-heart-valve-system-for-the-treatment-of-severe-aortic-stenosis-current-evidence-and-future-directions/ DOI: https://doi.org/10.17925/HI.2020.14.2.86
Elkoumy A, Jose J, Terkelsen CJ, Nissen H, Gunasekaran S, Abdelshafy M, Seth A, Elzomor H, Kumar S, Bedogni F, Ielasi A, Dora SK, Chandra S, Parikh K, Unic D, Wijns W, Baumbach A, Mylotte D, Serruys P, Soliman O. Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis-A Multicenter Real-World Experience. J Clin Med. 2022 Jan 15;11(2):443. doi: 10.3390/jcm11020443. PMID: 35054137; PMCID: PMC8779274. DOI: https://doi.org/10.3390/jcm11020443
Amat-Santos IJ, García-Gómez M, de Marco F, Won-Keun K, Brito J, Halim J, Jose J, Sengotuvelu G, Seth A, Terkelsen C, Protasiewicz M, Bonilla N, García B, Sánchez-Luna JP, Blasco-Turrión S, González JC, González-Bartol E, Ijsselmuiden AJJ, Gómez-Salvador I, Carrasco Moraleja M, San Román A. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study. Rev Esp Cardiol (Engl Ed). 2023 Mar 9:S1885-5857(23)00067-1. English, Spanish. doi: 10.1016/j.rec.2023.03.002. Epub ahead of print. PMID: 36898524. DOI: https://doi.org/10.1016/j.rec.2023.03.002
Barki M, Ielasi A, Buono A, Maliandi G, Pellicano M, Bande M, Casilli F, Messina F, Uccello G, Briguglia D, Medda M, Tespili M, Donatelli F. Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry. J Clin Med. 2022 Feb 12;11(4):959. doi: 10.3390/jcm11040959. PMID: 35207232; PMCID: PMC8876233. DOI: https://doi.org/10.3390/jcm11040959
García-Gómez M, Delgado-Arana JR, Halim J, De Marco F, Trani C, Martin P, Won-Keun K, Montorfano M, den Heijer P, Bedogni F, Sardella G, IJsselmuiden AJJ, Campante Teles R, Aristizabal-Duque CH, Gordillo X, Santos-Martinez S, Barrero A, Gómez-Salvador I, Ancona M, Redondo A, Román JAS, Amat-Santos IJ. Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients. Catheter Cardiovasc Interv. 2022 Feb;99(3):889-895. doi: 10.1002/ccd.29923. Epub 2021 Aug 14. PMID: 34390296. DOI: https://doi.org/10.1002/ccd.29923
Kawashima H, Wang R, Mylotte D, Jagielak D, De Marco F, Ielasi A, Onuma Y, den Heijer P, Terkelsen CJ, Wijns W, Serruys PW, Soliman O. Quantitative Angiographic Assessment of Aortic Regurgitation after Transcatheter Aortic Valve Implantation among Three Balloon-Expandable Valves. Glob Heart. 2021 Mar 19;16(1):20. doi: 10.5334/gh.959. PMID: 33833944; PMCID: PMC7977026. DOI: https://doi.org/10.5334/gh.959
Santos-Martinez S, Halim J, Castro-Mejía A, De Marco F, Trani C, Martin P, Infusino F, Ancona M, Moreno R, den Heijer P, Nombela-Franco L, Bedogni F, Sardella G, Montorfano M, Revilla-Orodea A, Delgado-Arana JR, Barrero A, Gómez-Salvador I, IJsselmuiden AJJ, Redondo A, Gutiérrez H, Serrador A, Serruys PW, Román JAS, Amat-Santos IJ. Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances. Int J Cardiol. 2022 Mar 15;351:25-31. doi: 10.1016/j.ijcard.2021.12.049. Epub 2022 Jan 1. PMID: 34979152. DOI: https://doi.org/10.1016/j.ijcard.2021.12.049
Gupta P, Arora S, Qamar A, Gupta M, Seth A. Current status of transcatheter aortic valve replacement in India. Cardiovasc Diagn Ther. 2020 Feb;10(1):83-88. doi: 10.21037/cdt.2019.05.04. PMID: 32175230; PMCID: PMC7044098. DOI: https://doi.org/10.21037/cdt.2019.05.04
Sharma SK, Rao RS, Chandra P, Goel PK, Bharadwaj P, Joseph G, Jose J, Mahajan AU, Mehrotra S, Sengottovelu G, Ajit Kumar VK, Manjunath CN, Abhaichand RK, Sethi R, Seth A; Collaborators. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study. EuroIntervention. 2020 Aug 28;16(5):421-429. doi: 10.4244/EIJ-D-19-00413. Erratum in: EuroIntervention. 2020 Aug 28;16(5):429. PMID: 31566572. DOI: https://doi.org/10.4244/EIJ-D-19-00413
Todaro D, Picci A, Barbanti M. Technical characteristics and evidence to date for FDA-and CE Mark-approved valves. 2017; 11.
Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012 May 3;366(18):1696-704. doi: 10.1056/NEJMoa1202277. Epub 2012 Mar 26. Erratum in: N Engl J Med. 2012 Aug 30;367(9):881. PMID: 22443478. DOI: https://doi.org/10.1056/NEJMoa1202277
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17. Erratum in: Circulation. 2021 Feb 2;143(5):e229. Erratum in: Circulation. 2023 Aug 22;148(8):e8. PMID: 33332150.
Nakashima M, Watanabe Y. Transcatheter Aortic Valve Implantation in Small Anatomy: Patient Selection and Technical Challenges. Interv Cardiol. 2018 May;13(2):66-68. doi: 10.15420/icr.2017:28:1. PMID: 29928310; PMCID: PMC5980651. DOI: https://doi.org/10.15420/icr.2017:28:1
Conzelmann LO, Würth A, Schymik G, Schröfel H, Anusic T, Temme S, Tzamalis P, Gerhardus J, Mukherjee C, Gonska BD, Schmitt C, Mehlhorn U. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry. Eur J Cardiothorac Surg. 2018 Oct 1;54(4):752-761. doi: 10.1093/ejcts/ezy130. PMID: 29617804. DOI: https://doi.org/10.1093/ejcts/ezy130
Yamamoto M, Shimura T, Kano S, Kagase A, Kodama A, Koyama Y, Watanabe Y, Tada N, Takagi K, Araki M, Shirai S, Hayashida K. Impact of preparatory coronary protection in patients at high anatomical risk of acute coronary obstruction during transcatheter aortic valve implantation. Int J Cardiol. 2016 Aug 15;217:58-63. doi: 10.1016/j.ijcard.2016.04.185. Epub 2016 May 4. PMID: 27179209. DOI: https://doi.org/10.1016/j.ijcard.2016.04.185
Akinseye OA, Jha SK, Ibebuogu UN. Clinical outcomes of coronary occlusion following transcatheter aortic valve replacement: A systematic review. Cardiovasc Revasc Med. 2018 Mar;19(2):229-236. doi: 10.1016/j.carrev.2017.09.006. Epub 2017 Sep 12. PMID: 29102344. DOI: https://doi.org/10.1016/j.carrev.2017.09.006
Lee CH, Inohara T, Hayashida K, Park DW. Transcatheter Aortic Valve Replacement in Asia: Present Status and Future Perspectives. JACC Asia. 2021 Dec 7;1(3):279-293. doi: 10.1016/j.jacasi.2021.10.006. PMID: 36341218; PMCID: PMC9627874. DOI: https://doi.org/10.1016/j.jacasi.2021.10.006
Watanabe Y, Hayashida K, Takayama M, Mitsudo K, Nanto S, Takanashi S, Komiya T, Kuratani T, Tobaru T, Goto T, Lefèvre T, Sawa Y, Morice MC. First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: the Massy study group vs. the PREVAIL JAPAN trial. J Cardiol. 2015 Feb;65(2):112-6. doi: 10.1016/j.jjcc.2014.05.001. Epub 2014 Jun 11. PMID: 24927855. DOI: https://doi.org/10.1016/j.jjcc.2014.05.001
Yoon SH, Ohno Y, Araki M, Barbanti M, Lin MS, Ahn JM, Yang DH, Kim YH, Immé S, Gulino S, Tamburino CI, Sgroi C, Park DW, Kang SJ, Lee SW, Lee CW, Park SW, Muramatsu T, Kao HL, Tamburino C, Park SJ. Comparison of aortic root anatomy and calcification distribution between Asian and Caucasian patients who underwent transcatheter aortic valve implantation. Am J Cardiol. 2015 Nov 15;116(10):1566-73. doi: 10.1016/j.amjcard.2015.08.021. Epub 2015 Aug 31. PMID: 26428022. DOI: https://doi.org/10.1016/j.amjcard.2015.08.021
Khan JM, Kamioka N, Lisko JC, Perdoncin E, Zhang C, Maini A, Chen M, Li Y, Ludwig S, Westermann D, Amat Santos IJ, Kalińczuk Ł, Sinning JM, Kawaguchi T, Fuku Y, Cheema AN, Félix-Oliveira A, Yamamoto M, Kagase A, Codner P, Valle RD, Iyer VS, Kim HS, Lin MS, Maini B, Rodriguez R, Montorfano M, Ancona MB, Tada N, Miyasaka M, Ahmad H, Ruggiero NJ, Torguson R, Ben-Dor I, Shults CC, Weissman G, Lederman RJ, Greenbaum AB, Babaliaros VC, Waksman R, Rogers T. Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction Model. JACC Cardiovasc Interv. 2023 Feb 27;16(4):415-425. doi: 10.1016/j.jcin.2022.11.018. PMID: 36858660; PMCID: PMC9991077. DOI: https://doi.org/10.1016/j.jcin.2022.11.018
Delgado-Arana JR, Gordillo-Monge MX, Halim J, De Marco F, Trani C, Martin P, Infusino F, Ancona M, den Heijer P, Bedogni F, Nombela Franco L, Moreno R, Sargella G, Montorfano M, Aristizabal-Duque C, Romero-Delgado T, Santos S, Barrero A, Gomez Salvador I, IJsselmuiden S, Redondo Diéguez A, San Román Calvar JA, Amat-Santos IJ. Early clinical and haemodynamic matched comparison of balloon-expandable valves. Heart. 2022 May;108(9):725-732. doi: 10.1136/heartjnl-2021-319349. Epub 2021 Jul 20. PMID: 34285104. DOI: https://doi.org/10.1136/heartjnl-2021-319349
Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation. 2013 Jan 22;127(3):397-407. doi: 10.1161/CIRCULATIONAHA.112.142000. PMID: 23339094. DOI: https://doi.org/10.1161/CIRCULATIONAHA.112.142000